Trials / Completed
CompletedNCT06085391
Testing the Efficacy of the REThink Emotions Platform in a Full-scale SMART Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 185 (actual)
- Sponsor
- Babes-Bolyai University · Academic / Other
- Sex
- All
- Age
- 8 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
This activity will have the objective of testing the validity of the integrated in-game assessment and personalized REThinkEMOTIONS platform in the prevention of emotional disorders in youth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | REThink Game | REThink Game is the therapeutic game that uses psychological science to help youths find their superhero emotional strengths! It is composed of seven levels, each training a specific emotion regulation ability: emotion recognition, mindfulness and relaxation, cognitive change, positive bias, distinction between useful and useless thoughts, problem solving and compassion. |
| OTHER | MoodWheel | Mood Wheel is a web and mobile-based app that uses experience sampling procedures for the assessment of current/previous distress and positive emotions. The aim of the app is to inquire about the valence, control and functionality of users' emotions. |
| OTHER | PsyPills | PsyPills is a self-help psycho-educational instrument intended to build stress resilience and to target (only) mild and transient negative mood states, alone or in combination with other methods/instruments. Psychological Pills (PsyPills) are inspired by Rational-Emotive \& Cognitive-Behavioral Therapy (CBT/REBT), which has strong evidence for its efficacy/effectiveness in human development/health promotion and in the treatment of a variety of psychological conditions. The PsyPills app was tested in a pilot study and showed positive effects on reducing distress. |
Timeline
- Start date
- 2023-10-07
- Primary completion
- 2023-11-10
- Completion
- 2023-12-31
- First posted
- 2023-10-17
- Last updated
- 2024-01-05
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT06085391. Inclusion in this directory is not an endorsement.